The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday. The...
Hims & Hers CEO Andrew Dudum defended the telehealth company amid a Federal Trade Commission lawsuit over its data sharing practices. In a wide-ranging...
In this photo illustration, the stock market information of Synchrony Financial displayed on a smartphone while the logo of Synchrony Financial seen in the...
Nvidia is attempting to turn its artificial intelligence chips into Wall Street's newest asset class, partnering with six large asset managers on a $500...
CNBC's Jim Cramer said Thursday earnings season has revealed investing themes he thinks will produce the market's best buying opportunities."I love themes. They help...
As Europe endures another summer of record-breaking heat, Asian travelers continue to flock to the continent, with little sign that soaring temperatures are dampening...
